|
 |
Discovery of New Antibiotic and Drug Agents (Patents Pending)
Bacterial cells produce anti-cancer and antibiotic drugs, as well as other potential medications and medicinal preparations. Microorganisms produce antibiotics with varying chemical natures and structures as well as therapeutic uses. Many new drugs are prepared through genetic manipulation of existing bacterial codes. Many experts in the field of microbiology believe that only ten percent of the total microbial population of the earth has been isolated and characterized.
GBI encourages drug exploration within populations of naturally occurring organisms. Our most prominent research area is the isolation of new drugs using alkane enrichment. To further exploit this promising field of research, GBI wishes to engage in a strategic partnership with a pharmaceutical firm actively engaged in drug research and discovery.
Due to the ever-increasing resistance of pathogenic bacteria to our current arsenal of antibiotics, a great need exists for the isolation and discovery of new antibiotics and other drug agents. If microorganisms have been traditionally used as a source of antibiotics and other drugs, the search should intensify for the isolation of naturally-occurring bacterial cells or fungal cells that may produce beneficial drugs or medications.
GBI's approach using alkane enrichment is contrary to the current method of genetically altering existing bacterial species or other microbial agents.
|
|
Related Links
Whitepapers
Downloadable PDF docs
|
|
